Literature DB >> 19484376

Evaluation of relationship between HIF-1alpha immunoreactivity and stage, grade, angiogenic profile and proliferative index in bladder urothelial carcinomas.

Hale Deniz1, Metin Karakök, Faruk Yagci, Muhammet Emin Güldür.   

Abstract

Hypoxia-inducible factor-1alpha (HIF-1alpha) is a critical regulatory protein of cellular response to hypoxia. In this study, we evaluated the relationship of HIF-1alpha with clinicopathologic parameters such as tumor stage and grade, as well as angiogenic profile and proliferation index. The immunoreactivity of HIF-1alpha was assessed in 70 cases of primary bladder urothelial carcinoma. Vascular endothelial growth factor (VEGF) and microvessel density (MVD) were used to evaluate the angiogenic profile. MVD was calculated by immunohistochemical staining of endothelial cells with CD34. Proliferation index was determined by the percentage of Ki-67 nuclear staining in tumor cells. There was a significant relationship between HIF-1alpha immunoreactivity and stage, as well as histologic grade of the tumor (P < 0.001). HIF-1alpha immunoreactivity was also closely related to VEGF expression (P < 0.001), MVD (P = 0.002) and proliferation index (P < 0.001). VEGF, MVD and proliferation index were found to be closely related to tumor stage and histologic grade. There was no correlation between HIF-1alpha immunoreactivity and lamina propria (P = 0.13), muscularis propria (P = 0.009) or vascular invasion (P = 0.1). In this study, HIF-1alpha expression was found to be closely related to prognostic parameters in bladder urothelial carcinoma. For this reason, it may be a useful marker to determine the prognosis and to choose the appropriate treatment modality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484376     DOI: 10.1007/s11255-009-9590-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.

Authors:  A Jones; C Fujiyama; C Blanche; J W Moore; S Fuggle; D Cranston; R Bicknell; A L Harris
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer.

Authors:  R Bos; P J van Diest; J S de Jong; P van der Groep; P van der Valk; E van der Wall
Journal:  Histopathology       Date:  2005-01       Impact factor: 5.087

3.  Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.

Authors:  R Bos; H Zhong; C F Hanrahan; E C Mommers; G L Semenza; H M Pinedo; M D Abeloff; J W Simons; P J van Diest; E van der Wall
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

4.  Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.

Authors:  Vasilios E Theodoropoulos; Andreas C Lazaris; Ioannis Kastriotis; Chariclia Spiliadi; George E Theodoropoulos; Vasiliki Tsoukala; Efstratios Patsouris; Frank Sofras
Journal:  BJU Int       Date:  2005-02       Impact factor: 5.588

Review 5.  HIF-1 and p53: communication of transcription factors under hypoxia.

Authors:  Tobias Schmid; Jie Zhou; Bernhard Brüne
Journal:  J Cell Mol Med       Date:  2004 Oct-Dec       Impact factor: 5.310

6.  Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.

Authors:  Zivko Popov; Sixtina Gil-Diez-De-Medina; Vincent Ravery; Andras Hoznek; Sylvie Bastuji-Garin; Marie-Aude Lefrere-Belda; Claude C Abbou; Dominique K Chopin
Journal:  Urol Oncol       Date:  2004 Mar-Apr       Impact factor: 3.498

Review 7.  Molecular and histological markers in urothelial carcinomas of the upper urinary tract.

Authors:  Stephanie Eltz; Eva Comperat; Olivier Cussenot; Morgan Rouprêt
Journal:  BJU Int       Date:  2008-04-02       Impact factor: 5.588

8.  p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma.

Authors:  Andrés Rodríguez-Alonso; Salvador Pita-Fernández; Joaquín González-Carreró; José Luis Nogueira-March
Journal:  Eur Urol       Date:  2002-02       Impact factor: 20.096

9.  Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.

Authors:  C-Y Chai; W-T Chen; W-C Hung; W-Y Kang; Y-C Huang; Y-C Su; C-H Yang
Journal:  J Clin Pathol       Date:  2007-10-01       Impact factor: 3.411

10.  Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.

Authors:  Midori Yamakawa; Louis X Liu; Taro Date; Adam J Belanger; Karen A Vincent; Geoffrey Y Akita; Takayuki Kuriyama; Seng H Cheng; Richard J Gregory; Canwen Jiang
Journal:  Circ Res       Date:  2003-09-04       Impact factor: 17.367

View more
  18 in total

1.  Angiogenesis in upper tract urothelial carcinoma associated with Balkan endemic nephropathy.

Authors:  Ljubinka Jankovic Velickovic; Ana Ristic Petrovic; Slavica Stojnev; Zana Dolicanin; Takanori Hattori; Hiroyuki Sugihara; Ken-ichi Mukaisho; Mariola Stojanovic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

2.  Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.

Authors:  Le Tao; Jianxin Qiu; Ming Jiang; Wenbin Song; Shuyuan Yeh; Hong Yu; Lijuan Zang; Shujie Xia; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2016-05-11       Impact factor: 6.261

3.  The investigation of tumoral angiogenesis with HIF-1 alpha and microvessel density in women with endometrium cancer.

Authors:  Aysun Aybatlı; Cenk Sayın; Petek Balkanlı Kaplan; Füsun Varol; Semsi Altaner; Necdet Süt
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-03-01

Review 4.  The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development.

Authors:  Paulina Wigner; Radosław Grębowski; Michał Bijak; Joanna Saluk-Bijak; Janusz Szemraj
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

5.  A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4.

Authors:  Wen Zhang; Keli Ge; Qian Zhao; Xiufen Zhuang; Zhenling Deng; Lingling Liu; Jie Li; Yu Zhang; Ying Dong; Youhui Zhang; Shuren Zhang; Binlei Liu
Journal:  Oncotarget       Date:  2015-08-21

6.  Time-intensity curve parameters in rectal cancer measured using endorectal ultrasonography with sterile coupling gels filling the rectum: correlations with tumor angiogenesis and clinicopathological features.

Authors:  Yong Wang; Lin Li; Yi-Xiang J Wang; Ning-Yi Cui; Shuang-Mei Zou; Chun-Wu Zhou; Yu-Xin Jiang
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

7.  Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma.

Authors:  Wei Wang; Haowen Jiang; Hechen Zhu; Hu Zhang; Jian Gong; Limin Zhang; Qiang Ding
Journal:  Oncol Lett       Date:  2012-12-27       Impact factor: 2.967

8.  CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.

Authors:  Yasuyoshi Miyata; Yuji Sagara; Shin-ichi Watanabe; Akihiro Asai; Tomohiro Matsuo; Kojiro Ohba; Tomayoshi Hayashi; Hideki Sakai
Journal:  Virchows Arch       Date:  2013-08-25       Impact factor: 4.064

9.  HIF-1, GLUT1, endoglin, and BIRC5 expression in urine samples obtained from patients with bladder malignancies - after photodynamic diagnosis (PDD).

Authors:  Michał Markowski; Marek Lipiński; Anna Krzeslak; Ewa Forma; Magdalena Bryś; Waldemar Różański
Journal:  Cent European J Urol       Date:  2012-09-04

10.  Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer.

Authors:  B A Hunter; A Eustace; J J Irlam; H R Valentine; H Denley; K K Oguejiofor; R Swindell; P J Hoskin; A Choudhury; C M West
Journal:  Br J Cancer       Date:  2014-06-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.